Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
Article in Pharmaceuticals (March 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
A Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-α Inhibitors in the United States Food and Drug Administration's Adverse Event Reporting System Database
Article in Journal of Oral and Maxillofacial Surgery (July 2023)
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes
Article in Endocrinology Diabetes & Metabolism (April 2021)